Shares of direct-to-consumer telehealth business Hims & Hers Health (HIMS 0.61%) are up 30% since the company reported its Q4 earnings . It often feels like you've missed the boat when you sit there reading about another stock that got hot before you realized what was happening . The company started with taboo conditions for men like erectile dysfunction, but has vastly expanded to what CEO Andrew Dudum outlined .